Among other things, there is no guarantee that planned or ongoing studies will be completed as planned, that future study results will be consistent with expectations or study results to date, that retatrutide will prove to be a safe and effective treatment for type 2 diabetes, obesity or other potential indications, that retatrutide will receive regulatory approval, or that Lilly will execute its strategy as expected
Tri-Luma cream containing hydroquinone 4%, tretinoin 0.05%, and fluocinolone acetonide 0.1% has been authorized by the FDA for melasma management and should be applied once daily on the affected facial areas for at least 8 weeks (Ferreira Cestari et al., 2007
10.3109/03602532.2011.552910 Drug Metab
Int J Biochem Cell Biol (2018) 96:18
However, these benefits come with the trade-off of requiring larger syringes or split doses at higher doses, which adds complexity and increases the risk of dosing errors